Johnson & Johnson

Johnson & Johnson proposes to pay nearly $9 bn to settle lawsuits in US

10 Apr 2023

Hetero acquires Johnson & Johnson’s Telangana plant

26 Oct 2022

Johnson & Johnson fined $8 bn for hiding fact about drug causing breast growth in men

10 Oct 2019

And now, formaldehyde found in J&J’s baby shampoo

01 Apr 2019

Johnson & Johnson is facing regulatory scrutiny over most of its products, including its baby care products, over health concerns

J&J fined Rs74.5 lakh for its first faulty hip implant in India

11 Mar 2019

Of the over 4,000 patients fitted with the Articular Surface Replacement (ASR) hip implant in India, just about 844 have been traced by the company till date

J&J settles US hip implant claims for $120 mn; posts higher Q4 revenues

23 Jan 2019

J&J told to stop using its baby powder raw material in India

21 Dec 2018

Reports quoting an unnamed senior CDSCO official said on Thursday that Johnson & Johnson has been served with a written order to stop using the "huge quantities" of raw materials stocked in its plants in India

Indian drug regulator may revive probe to J&J’s baby powder: Reuters

18 Dec 2018

J&J may have to pay up to Rs1.23 cr for defective hip implant

30 Nov 2018

As per the formula approved by the union health ministry, Johnson & Johnson will have to pay compensation varying from Rs1,23 crore for those young patients (20 years and less) with over 50 per cent deformity to Rs30 lakh for the elderly (65 years and over) with up to 30 per cent deformity

J&J says will work with Indian govt on compensation for defective hip implants

07 Sep 2018

Court orders J&J to pay record $4.69 bn in Baby Powder case

14 Jul 2018

A jury in the US on Thursday ordered Johnson & Johnson (J&J) to pay a record $4.69 billion to 22 women who alleged that the company’s talc-based products, including its baby powder, contain asbestos and caused them to develop ovarian cancer

China’s Sinocare in talks to buy J&J’s diabetes care units worth around $4 bn

24 Jan 2018

Missouri appeals court overturns $72-mn award in J&J talc cancer risk case

20 Oct 2017

Pfizer, J&J in legal battle that could shape biosimilars market

21 Sep 2017

Johnson & Johnson ordered to pay record $417 mn in talcum powder case

22 Aug 2017

Echeverria who filed the law suit alleged that Johnson & Johnson failed to adequately warn consumers even as it was fully aware of the talcum powder’s potential cancer risks

Johnson & Johnson sued in Australia over vaginal mesh implants

04 Jul 2017

J&J’s diabetes drug Invokana linked to foot and leg amputations, warns US FDA

17 May 2017

US jury orders J&J to pay over $110 mn over talcum claim

05 May 2017

J&J, Novartis, Takeda, keen on buying controlling stake in Brazilian drug maker Hypermarcas

26 Apr 2017

Johnson & Johnson succeeds in $30-bn tender offer for Actelion

31 Mar 2017

J&J had clinched the deal in December after raising its offer to $280 per share or $30 billion in cash, which included spinning off Actelion's research and development pipeline

Johnson & Johnson in talks to buy commercial portfolio of Actelion

30 Dec 2016

Johnson & Johnson resumes merger talks with Actelion Pharmaceuticals

26 Dec 2016

Actelion in exclusive negotiations with J&J after talks with Sanofi

22 Dec 2016

J&J being sued over Risperidal causing breasts in men

16 Dec 2016

Actelion says J&J backs off, in talks with another suitor

14 Dec 2016